Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) released a profit for its full year that Increased, from last year
The company's bottom line totaled RMB730.073 million, or RMB0.82 per share. This compares with RMB606.096 million, or RMB0.68 per share, last year.
The company's revenue for the period rose 6.7% to RMB5.508 billion from RMB5.160 billion last year.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd earnings at a glance (GAAP) :
-Earnings: RMB730.073 Mln. vs. RMB606.096 Mln. last year.-EPS: RMB0.82 vs. RMB0.68 last year.-Revenue: RMB5.508 Bln vs. RMB5.160 Bln last year.
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.